|
1
|
Field JK, Oudkerk M, Pedersen JH and Duffy
SW: Prospects for population screening and diagnosis of lung
cancer. Lancet. 382:732–741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang L, Yu C, Liu Y, Wang J, Li C, Wang Q,
Wang P, Wu S and Zhang ZJ: Lung cancer mortality trends in China
from 1988 to 2013: New challenges and opportunities for the
government. Int J Environ Res Public Health. 13:E10522016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reck M, Popat S, Reinmuth N, De Ruysscher
D, Kerr KM and Peters S; ESMO Guidelines Working Group, :
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 25 (Suppl 3):iii27–iii39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pao W and Girard N: New driver mutations
in non-small-cell lung cancer. Lancet Oncol. 12:175–180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Araujo LH and Carbone DP: Non-small cell
lung cancer genomics around the globe: Focus on ethnicity. J Thorac
Dis. 9:E392–E394. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lv X, Li CY, Han P and Xu XY:
MicroRNA-520a-3p inhibits cell growth and metastasis of non-small
cell lung cancer through PI3K/AKT/mTOR signaling pathway. Eur Rev
Med Pharmacol Sci. 22:2321–2327. 2018.PubMed/NCBI
|
|
7
|
Fei X, Zhang J, Zhao Y, Sun M, Zhao H and
Li S: miR-96 promotes invasion and metastasis by targeting GPC3 in
non-small cell lung cancer cells. Oncol Lett. 15:9081–9086.
2018.PubMed/NCBI
|
|
8
|
Song B, Ji W, Guo S, Liu A, Jing W, Shao
C, Li G and Jin G: miR-545 inhibited pancreatic ductal
adenocarcinoma growth by targeting RIG-I. FEBS Lett. 588:4375–4381.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cosín-Tomás M, Antonell A, Lladó A,
Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M,
Sanchez-Valle R, et al: Plasma miR-34a-5p and miR-545-3p as early
biomarkers of Alzheimer's disease: Potential and limitations. Mol
Neurobiol. 54:5550–5562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du B, Wang Z, Zhang X, Feng S, Wang G, He
J and Zhang B: MicroRNA-545 suppresses cell proliferation by
targeting cyclin D1 and CDK4 in lung cancer cells. PLoS One.
9:e880222014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gheldof A, Hulpiau P, van Roy F, De Craene
B and Berx G: Evolutionary functional analysis and molecular
regulation of the ZEB transcription factors. Cell Mol Life Sci.
69:2527–2541. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
You J, Li Y, Fang N, Liu B, Zu L, Chang R,
Li X and Zhou Q: MiR-132 suppresses the migration and invasion of
lung cancer cells via targeting the EMT regulator ZEB2. PLoS One.
9:e918272014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cong N, Du P, Zhang A, Shen F, Su J, Pu P,
Wang T, Zjang J, Kang C and Zhang Q: Downregulated microRNA-200a
promotes EMT and tumor growth through the wnt/β-catenin pathway by
targeting the E-cadherin repressors ZEB1/ZEB2 in gastric
adenocarcinoma. Oncol Rep. 29:1579–1587. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Q, Zhang B, Sun L, Yan Q, Zhang Y,
Zhang Z, Su Y and Wang C: MicroRNA-130b targets PTEN to induce
resistance to cisplatin in lung cancer cells by activating
Wnt/β-catenin pathway. Cell Biochem Funct. 36:194–202. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brown BD and Naldini L: Exploiting and
antagonizing microRNA regulation for therapeutic and experimental
applications. Nat Rev Genet. 10:578–585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han L, Chen W, Xia Y, Song Y, Zhao Z,
Cheng H and Jiang T: MiR-101 inhibits the proliferation and
metastasis of lung cancer by targeting zinc finger E-box binding
homeobox 1. Am J Transl Res. 10:1172–1183. 2018.PubMed/NCBI
|
|
19
|
Zhang W, Qiao B and Fan J: Overexpression
of miR-4443 promotes the resistance of non-small cell lung cancer
cells to epirubicin by targeting INPP4A and regulating the
activation of JAK2/STAT3 pathway. Pharmazie. 73:386–392.
2018.PubMed/NCBI
|
|
20
|
Liao C, Xiao W, Zhu N, Liu Z, Yang J, Wang
Y and Hong M: MicroR-545 enhanced radiosensitivity via suppressing
Ku70 expression in Lewis lung carcinoma xenograft model. Cancer
Cell Int. 15:562015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Z, Dou C, Yao B, Xu M, Ding L, Wang Y,
Jia Y, Li Q, Zhang H, Tu K, et al: Ftx non coding RNA-derived
miR-545 promotes cell proliferation by targeting RIG-I in
hepatocellular carcinoma. Oncotarget. 7:25350–25365.
2016.PubMed/NCBI
|
|
22
|
Jia X, Liu X, Li M, Zeng Y, Feng Z, Su X,
Huang Y, Chen M and Yang X: Potential tumor suppressing role of
microRNA-545 in epithelial ovarian cancer. Oncol Lett.
15:6386–6392. 2018.PubMed/NCBI
|
|
23
|
Huang X and Lu S: MicroR-545 mediates
colorectal cancer cells proliferation through up-regulating
epidermal growth factor receptor expression in HOTAIR long
non-coding RNA dependent. Mol Cell Biochem. 431:45–54. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin X, Yang Z, Zhang P, Liu Y and Shao G:
miR-154 inhibits migration and invasion of human non-small cell
lung cancer by targeting ZEB2. Oncol Lett. 12:301–306. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fei D, Zhao K, Yuan H, Xing J and Zhao D:
MicroRNA-187 exerts tumor-suppressing functions in osteosarcoma by
targeting ZEB2. Am J Cancer Res. 6:2859–2868. 2016.PubMed/NCBI
|
|
26
|
Jiao A, Sui M, Zhang L, Sun P, Geng D,
Zhang W, Wang X and Li J: MicroRNA-200c inhibits the metastasis of
non-small cell lung cancer cells by targeting ZEB2, an
epithelial-mesenchymal transition regulator. Mol Med Rep.
13:3349–3355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Comijn J, Berx G, Vermassen P, Verschueren
K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy
F: The two-handed E box binding zinc finger protein SIP1
downregulates E-cadherin and induces invasion. Mol Cell.
7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi ZM, Wang L, Shen H, Jiang CF, Ge X, Li
DM, Wen YY, Sun HR, Pan MH, Li W, et al: Downregulation of miR-218
contributes to epithelial-mesenchymal transition and tumor
metastasis in lung cancer by targeting Slug/ZEB2 signaling.
Oncogene. 36:2577–2588. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qi S, Song Y, Peng Y, Wang H, Long H, Yu
X, Li Z, Fang L, Wu A, Luo W, et al: ZEB2 mediates multiple
pathways regulating cell proliferation, migration, invasion, and
apoptosis in glioma. PLoS One. 7:e388422012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Polakis P: Wnt signaling in cancer. Cold
Spring Harb Perspect Biol. 4:a0080522012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang XH, Cui YX, Wang ZM and Liu J:
Down-regulation of FOXR2 inhibits non-small cell lung cancer cell
proliferation and invasion through the Wnt/β-catenin signaling
pathway. Biochem Biophys Res Commun. 500:229–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou DD, Wang X, Wang Y, Xiang XJ, Liang
ZC, Zhou Y, Xu A, Bi CH and Zhang L: MicroRNA-145 inhibits hepatic
stellate cell activation and proliferation by targeting ZEB2
through Wnt/β-catenin pathway. Mol Immunol. 75:151–160. 2016.
View Article : Google Scholar : PubMed/NCBI
|
